Schinzel R - Search Results

1

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts.

Münch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, Vlassara H, Smith MA, Perry G, Riederer P. Münch G, et al. Among authors: schinzel r. J Neural Transm (Vienna). 1998;105(4-5):439-61. doi: 10.1007/s007020050069. J Neural Transm (Vienna). 1998. PMID: 9720973 Review.

2

The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation.

Münch G, Taneli Y, Schraven E, Schindler U, Schinzel R, Palm D, Riederer P. Münch G, et al. Among authors: schinzel r. J Neural Transm Park Dis Dement Sect. 1994;8(3):193-208. doi: 10.1007/BF02260940. J Neural Transm Park Dis Dement Sect. 1994. PMID: 7748463

3

Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease.

Thome J, Münch G, Müller R, Schinzel R, Kornhuber J, Blum-Degen D, Sitzmann L, Rösler M, Heidland A, Riederer P. Thome J, et al. Among authors: schinzel r. Life Sci. 1996;59(8):679-85. doi: 10.1016/0024-3205(96)00349-9. Life Sci. 1996. PMID: 8761018

4

Advanced glycation endproducts in ageing and Alzheimer's disease.

Münch G, Thome J, Foley P, Schinzel R, Riederer P. Münch G, et al. Among authors: schinzel r. Brain Res Brain Res Rev. 1997 Feb;23(1-2):134-43. doi: 10.1016/s0165-0173(96)00016-1. Brain Res Brain Res Rev. 1997. PMID: 9063589 Review.

5

Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress.

Loske C, Neumann A, Cunningham AM, Nichol K, Schinzel R, Riederer P, Münch G. Loske C, et al. Among authors: schinzel r. J Neural Transm (Vienna). 1998;105(8-9):1005-15. doi: 10.1007/s007020050108. J Neural Transm (Vienna). 1998. PMID: 9869332

6

High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression.

Neumann A, Schinzel R, Palm D, Riederer P, Münch G. Neumann A, et al. Among authors: schinzel r. FEBS Lett. 1999 Jun 25;453(3):283-7. doi: 10.1016/s0014-5793(99)00731-0. FEBS Lett. 1999. PMID: 10405161 Free article.

7

Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide.

Loske C, Gerdemann A, Schepl W, Wycislo M, Schinzel R, Palm D, Riederer P, Münch G. Loske C, et al. Among authors: schinzel r. Eur J Biochem. 2000 Jul;267(13):4171-8. doi: 10.1046/j.1432-1327.2000.01452.x. Eur J Biochem. 2000. PMID: 10866821 Free article.

8

AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?

Dukic-Stefanovic S, Schinzel R, Riederer P, Münch G. Dukic-Stefanovic S, et al. Among authors: schinzel r. Biogerontology. 2001;2(1):19-34. doi: 10.1023/a:1010052800347. Biogerontology. 2001. PMID: 11708614 Review.

9

Differential effects of "Advanced glycation endproducts" and beta-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y.

Kuhla B, Loske C, Garcia De Arriba S, Schinzel R, Huber J, Münch G. Kuhla B, et al. Among authors: schinzel r. J Neural Transm (Vienna). 2004 Mar;111(3):427-39. doi: 10.1007/s00702-003-0038-2. Epub 2003 Sep 15. J Neural Transm (Vienna). 2004. PMID: 14991463

10

Advanced glycation endproducts induce changes in glucose consumption, lactate production, and ATP levels in SH-SY5Y neuroblastoma cells by a redox-sensitive mechanism.

de Arriba SG, Loske C, Meiners I, Fleischer G, Lobisch M, Wessel K, Tritschler H, Schinzel R, Münch G. de Arriba SG, et al. Among authors: schinzel r. J Cereb Blood Flow Metab. 2003 Nov;23(11):1307-13. doi: 10.1097/01.WCB.0000090622.86921.0E. J Cereb Blood Flow Metab. 2003. PMID: 14600438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page